Tratamiento de la rinitis alergica con Ketotifeno: estudio doble ciego vs. placebo

Ramírez Chanona, Nelly; Campillo, Ramón; Báez Loyola, Carlos.
Alergia (Méx.) ; 33(1): 9-17, ene.-mar. 1986. ilus, tab
Artículo en Español | LILACS | ID: lil-46962

Documentos relacionados

  1. Nasal allergen challenge studies of allergic rhinitis: a guide for the practicing clinician.
  2. Sodium Chloride versus Lactose as a Carrier for House Dust Mite Allergen in Allergen Chamber Studies: A Clinical Study to Assess Noninferiority.
  3. Intranasal Steroid Use and Satisfaction in Allergic Rhinitis: A Cross-Sectional Study from an Asian Perspective.
  4. Changes in olfaction & quality of life following standard medical therapy in patients with intermittent & persistent allergic rhinitis.
  5. Validated allergen exposure chamber is plausible tool for the assessment of house dust mite-triggered allergic rhinitis.
  6. Sublingual Immunotherapy for Allergic Rhinitis: Is 2-Year Treatment Sufficient for Long-term Benefit?
  7. Clinical effectiveness of fluticasone furoate nasal spray for perennial allergic rhinitis in children: a comprehensive review.
  8. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
  9. Triamcinolone Acetonide in the Treatment of Perennial Allergic Rhinitis: A post hoc Analysis of Quality of Life during a Phase III Study.
  10. Efficacy and safety of intratonsillar immunotherapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial.